The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases

Abroad (travel likely)RecruitingPHASE1

Conditions

Lupus Nephritis · ANCA-associated Vasculitis · Membranous Nephropathy - PLA2R Induced · IgG4-Related Diseases

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Jinling Hospital, Nanjing, Jiangsu, China
Contact: Study coordinator (Xianghua Huang, MD) · hxhszb@163.com · 13770648824

Study leads

Zhihong Liu
Principal Investigator
Jinling Hospital, China

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related Disease

Lupus Nephritis · IgG4-related Disease

Abroad (travel likely)RecruitingEARLY_PHASE1

Wuhan, China

Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease

Lupus Nephritis · IgG4-related Disease

Abroad (travel likely)RecruitingEARLY_PHASE1

Wuhan, China

KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis

Glomerular Disease · Minimal Change Disease · IgA Nephropathy

Abroad (travel likely)Recruiting

Chuncheon, South Korea · Daegu, South Korea

Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

Lupus Nephritis (LN)

Abroad (travel likely)RecruitingPHASE1

Rochester, United States · Houston, United States